Navigation Links
AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
Date:4/30/2008

common stock (4,593) -

Exercise of stock options 181 17

Cash (used in) provided by financing

activities (4,412) 17

Increase (decrease) in cash and cash equivalents 4,531 (243)

Cash and cash equivalents at beginning of period 8,536 7,331

Cash and cash equivalents at end of period $13,067 $7,088

Supplemental disclosure of cash paid during

the period for:

Income taxes, net of refunds $115 $-

Non-cash investing activities:

Unrealized gain on available-for-sale securities $120 $6

2008 Projected

Reconciliation of projected net loss to Lower Upper

projected pro-forma EBITDA Range Range

Projected net loss $(1,350) $(850)

Interest income 3,000 3,000

Operating loss (4,350) (3,850)

Non-cash stock compensation expense 1,816 1,816

Depreciation and amortization 1,286 1,286

Amortization of software development costs 2,286 2,286

Projected pro-forma EBITDA $1,038 $1,538

Reconciliation of net (loss) income to Three Months Ended

pro-forma EBITDA March 31,

2008 2007

Net (loss) income $(467) $146

Provision for income taxes (61) (62)

Interest income
'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. AMICAS to Present at CIBC World Markets 18th Annual Healthcare Conference
2. LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
3. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
4. Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
5. Alexion Reports First Quarter 2008 Results
6. Masimo Reports First Quarter 2008 Financial Results
7. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
8. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
9. SuperGen Reports 2008 First Quarter Financial Results
10. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
11. Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)...  Peter Walter was chosen as winner of the ... on how proteins are transported between cellular compartments and ... cells use to handle stress tied to the aggregation ... biochemistry at the University of California, San Francisco. His ... human diseases related to defective protein folding and transport. ...
(Date:3/27/2015)... SHANGHAI , March 27, 2015 ... a leading open-access R&D capability and technology platform ... device industries, announced today that an Investigational New ... monoclonal antibody for rheumatoid arthritis has been accepted ... Administration (CFDA).  In September 2012, ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 Governor ... 2015 application period for 43North - the world’s largest ... including a grand prize of $1 million, six $500,000 ... from around the world to compete for prizes that ... enterprises in the Western New York region. , ...
(Date:3/26/2015)... 2015 PRC Clinical, a Silicon-Valley based ... management and executive appointments effective immediately. , Mike Catelani ... and member of the Board of Directors. Daniel Head ... Sue Dowden will assume the position of Senior Director ... Operations Officer (COO), has been appointed to the position ...
Breaking Biology Technology:German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3
... named new Corporate Vice President, Business, Development to spearhead global business ... and moving forward strongly on many ... ... global,developer, manufacturer and seller of laser, light-based and radiofrequency,devices for surgical, ...
... HapMap Consortium today published analyses of its second-generation ... times more markers than the initial version unveiled ... Nature, the consortium describes how the higher resolution ... involved in common diseases, explore the structure of ...
... AMCS ),a leader in radiology and medical image ... and meet with investors at,the CIBC World Markets 18th ... http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), WHEN: -- Tuesday, ... 10:20 a.m. (Eastern Time), 9:20 a.m. ...
Cached Biology Technology:Lumenis Ltd. Announces Appointment of Corporate Vice President, Business Development in support of the company's long-term growth strategy 2Consortium publishes Phase II map of human genetic variation 2Consortium publishes Phase II map of human genetic variation 3Consortium publishes Phase II map of human genetic variation 4Consortium publishes Phase II map of human genetic variation 5Consortium publishes Phase II map of human genetic variation 6
(Date:3/12/2015)... 2015 The mascots of the Atlantic Coast ... of Wake Forest Baptist Medical Center. They stopped by ... ACC Men,s Basketball Tournament. Young patients enjoyed bonding with ... their autographs. Brenner Children,s Hospital is the ... only children,s hospital in northwest North Carolina ...
(Date:3/10/2015)...  Continuing its 167-year history of offering the Best, ... The Eye Scanning Password Authenticator , a device that ... websites or sensitive data. Employing the same ... the device has a small camera that scans and ... converting them into an encrypted ID that cannot be ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ) ... Biometrics Market Forecast and Opportunities, 2020" report ... biometric authentication systems is projected to grow at ... The driving forces for this highly competitive ... and constant development in technology. In 2014, government ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3
... evidence from the Mladec Caves in Moravia, Czech Republic, excavated ... first time, through modern radiocarbon dating, to be the oldest ... Europe. , A team of researchers from the Natural History ... and from the Washington University in St. Louis, USA recently ...
... Reproduction includes a special paper by a team of ... in shorter life expectancy and reduced body weight in ... in women, such as abnormal numbers of chromosomes in ... effects on offspring from delayed motherhood have been only ...
... previous work, researchers at the University of Pennsylvania School ... cancer that closely mimics disease progression in humans. From ... deadly disease. Advanced pancreatic cancer is among the most ... chemotherapy of only 17 to 28 percent of patients, ...
Cached Biology News:Oldest cranial, dental and postcranial fossils of early modern European humans confirmed 2Disease progression model of pancreatic cancer developed by Penn researchers 2Disease progression model of pancreatic cancer developed by Penn researchers 3
... Sensitivity Freezing Point Osmometer for 10 L sample. Ideal for small volume applications, including pediatric, neonatal, ... Ready to run in less than 3 minutes after turn-on. ... ... ...
X-Gal, 100 mg. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzy...
Mouse/Rat WNK1 Affinity Purified Polyclonal Ab...
... Removal of excess dye terminators, template ... from the true sequencing products have proved ... This product is designed to work with ... BigDyeTM and DYEnamicTM ET. The unique uniformity ...
Biology Products: